Endo wooed by $1.2M incentives from PA; Wellspring acquired by Sentinel, Ancor;

> Pennsylvania has offered Endo Pharmaceuticals ($ENDP) $1.2 million in incentives to remain in The Keystone State in exchange for a promise of 154 jobs in three years. Story

> Wellspring Pharmaceutical, a Canadian manufacturer of specialty and OTC drugs, has been acquired by Sentinel Capital Partners and Ancor Capital Partners. Release

> Hebei Aoxing Pharmaceutical Group, unit of China's Aoxing Pharmaceuticals ($AXN), has received government funding of $315,000 for manufacturing plant improvements. News

> Lonza has announced a development and manufacturing agreement with Genmab to produce HuMax-TF, a tumor-fighting antibody-drug conjugate. Release

> Kenya's Universal Corp. has been prequalified by the World Health Organization to manufacture the HIV drug, Lamozido. Item

> A news organization's investigation has uncovered drug counterfeiting operations in parts of Delhi and adjoining western parts of Uttar Pradesh. Story

> Organization and funding troubles plague U.S. efforts to develop and produce bioterror vaccines. Story

> Adeona Pharmaceuticals ($AEN) will provide commercial-scale manufacturing for Chicago-based F&F Foods of wellZin, an oral zinc lozenge to ease symptoms of the common cold. Release

> The FDA will provide $2 million in support of two regulatory science and innovation centers at the University of Maryland and Georgetown University. Story

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.